November 4, 2024
SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy) significantly reduced hospital admissions for all causes — not just cardiac — and overall hospitalization time […]
November 4, 2024
Europe is grappling with general neurology workforce shortages that could have serious consequences for patient care. The European Academy of Neurology (EAN) warned in a recently […]
November 4, 2024
TOPLINE: A fasting-mimicking diet (FMD) restored kidney function in a rodent model and promoted renoprotection in patients with chronic kidney disease (CKD) by reducing proteinuria and […]
November 4, 2024
CHICAGO — The investigational monoclonal antibody batoclimab showed safety and rapid and significant improvement in key markers of Graves’ disease, with some patients who failed to […]
November 4, 2024
(Reuters) -Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term skin condition called rosacea. […]
November 4, 2024
PHILADELPHIA — New research challenges the traditional practice of continuing vasoconstrictor therapy for 5 days after endoscopic variceal ligation (EVL) for acute variceal bleeding, finding that […]
November 4, 2024
TOPLINE: Patients with cancer who participated in the Medicare Low-Income Subsidy program were less likely to receive any systemic cancer therapy compared with patients not participating […]
November 4, 2024
AMSTERDAM — The monoclonal antibody bimekizumab (Bimzelx) achieves significant and clinically meaningful improvements in moderate to severe hidradenitis suppurativa (HS) that are maintained well beyond the […]
November 4, 2024
Cannabis use may lead to thinning of the cerebral cortex in adolescents, research in mice and humans suggested. The multilevel study demonstrated that tetrahydrocannabinol (THC), an […]